Selected research
Market Structure
Global Glycobiology & Glycomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Glycobiology & Glycomics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Glycobiology & Glycomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glycobiology & Glycomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glycobiology & Glycomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Glycobiology & Glycomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glycobiology & Glycomics include Waters Corp, Thermo Fisher Scientific, Shimadzu Corp, Danaher Corp, Takara Bio, Sigma-Aldrich Corp, Prozyme, New England Biolabs and Bruker Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glycobiology & Glycomics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glycobiology & Glycomics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glycobiology & Glycomics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycobiology & Glycomics market size, projected growth trends, production technologies, key applications, and end-use industries.
Glycobiology & Glycomics Segment by Company
Waters Corp
Thermo Fisher Scientific
Shimadzu Corp
Danaher Corp
Takara Bio
Sigma-Aldrich Corp
Prozyme
New England Biolabs
Bruker Corp
Agilent Technologies
Glycobiology & Glycomics Segment by Type
Instruments
Kits
Enzymes
Eagents
Glycobiology & Glycomics Segment by Application
Immunology
Drug Discovery and Development
Diagnostics
Oncology
Others
Glycobiology & Glycomics Segment by Region
North America
United States
Canada
Europe
v
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycobiology & Glycomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycobiology & Glycomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycobiology & Glycomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glycobiology & Glycomics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycobiology & Glycomics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glycobiology & Glycomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Glycobiology & Glycomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Kits
- Enzymes
- Eagents
Applications
- Immunology
- Drug Discovery and Development
- Diagnostics
- Oncology
- Others
Companies covered
- Waters Corp
- Thermo Fisher Scientific
- Shimadzu Corp
- Danaher Corp
- Takara Bio
- Sigma-Aldrich Corp
- Prozyme
- New England Biolabs
- Bruker Corp
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Glycobiology & Glycomics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Glycobiology & Glycomics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Glycobiology & Glycomics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Glycobiology & Glycomics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Glycobiology & Glycomics Market Dynamics
- 2.1 Glycobiology & Glycomics Industry Trends
- 2.2 Glycobiology & Glycomics Industry Drivers
- 2.3 Glycobiology & Glycomics Industry Opportunities and Challenges
- 2.4 Glycobiology & Glycomics Industry Restraints
3 Glycobiology & Glycomics Market by Manufacturers
- 3.1 Global Glycobiology & Glycomics Revenue by Manufacturers (2021-2026)
- 3.2 Global Glycobiology & Glycomics Sales by Manufacturers (2021-2026)
- 3.3 Global Glycobiology & Glycomics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Glycobiology & Glycomics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glycobiology & Glycomics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glycobiology & Glycomics Manufacturers, Product Type & Application
- 3.7 Global Glycobiology & Glycomics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glycobiology & Glycomics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glycobiology & Glycomics Players Market Share by Revenue in 2025
- 3.8.3 2025 Glycobiology & Glycomics Tier 1, Tier 2, and Tier 3
4 Glycobiology & Glycomics Market by Type
- 4.1 Glycobiology & Glycomics Type Introduction
- 4.1.1 Instruments
- 4.1.2 Kits
- 4.1.3 Enzymes
- 4.1.4 Eagents
- 4.2 Global Glycobiology & Glycomics Sales by Type
- 4.2.1 Global Glycobiology & Glycomics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glycobiology & Glycomics Sales by Type (2021-2032)
- 4.2.3 Global Glycobiology & Glycomics Sales Market Share by Type (2021-2032)
- 4.3 Global Glycobiology & Glycomics Revenue by Type
- 4.3.1 Global Glycobiology & Glycomics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glycobiology & Glycomics Revenue by Type (2021-2032)
- 4.3.3 Global Glycobiology & Glycomics Revenue Market Share by Type (2021-2032)
5 Glycobiology & Glycomics Market by Application
- 5.1 Glycobiology & Glycomics Application Introduction
- 5.1.1 Immunology
- 5.1.2 Drug Discovery and Development
- 5.1.3 Diagnostics
- 5.1.4 Oncology
- 5.1.5 Others
- 5.2 Global Glycobiology & Glycomics Sales by Application
- 5.2.1 Global Glycobiology & Glycomics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glycobiology & Glycomics Sales by Application (2021-2032)
- 5.2.3 Global Glycobiology & Glycomics Sales Market Share by Application (2021-2032)
- 5.3 Global Glycobiology & Glycomics Revenue by Application
- 5.3.1 Global Glycobiology & Glycomics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glycobiology & Glycomics Revenue by Application (2021-2032)
- 5.3.3 Global Glycobiology & Glycomics Revenue Market Share by Application (2021-2032)
6 Global Glycobiology & Glycomics Sales by Region
- 6.1 Global Glycobiology & Glycomics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glycobiology & Glycomics Sales by Region (2021-2032)
- 6.2.1 Global Glycobiology & Glycomics Sales by Region (2021-2026)
- 6.2.2 Global Glycobiology & Glycomics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Glycobiology & Glycomics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Glycobiology & Glycomics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Glycobiology & Glycomics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Glycobiology & Glycomics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Glycobiology & Glycomics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Glycobiology & Glycomics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Glycobiology & Glycomics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Glycobiology & Glycomics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Glycobiology & Glycomics Revenue by Region
- 7.1 Global Glycobiology & Glycomics Revenue by Region
- 7.1.1 Global Glycobiology & Glycomics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Glycobiology & Glycomics Revenue by Region (2021-2026)
- 7.1.3 Global Glycobiology & Glycomics Revenue by Region (2027-2032)
- 7.1.4 Global Glycobiology & Glycomics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Glycobiology & Glycomics Revenue (2021-2032)
- 7.2.2 North America Glycobiology & Glycomics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Glycobiology & Glycomics Revenue (2021-2032)
- 7.3.2 Europe Glycobiology & Glycomics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Glycobiology & Glycomics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Glycobiology & Glycomics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Glycobiology & Glycomics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Glycobiology & Glycomics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Waters Corp
- 8.1.1 Waters Corp Company Information
- 8.1.2 Waters Corp Business Overview
- 8.1.3 Waters Corp Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Waters Corp Glycobiology & Glycomics Product Portfolio
- 8.1.5 Waters Corp Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Glycobiology & Glycomics Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Shimadzu Corp
- 8.3.1 Shimadzu Corp Company Information
- 8.3.2 Shimadzu Corp Business Overview
- 8.3.3 Shimadzu Corp Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shimadzu Corp Glycobiology & Glycomics Product Portfolio
- 8.3.5 Shimadzu Corp Recent Developments
- 8.4 Danaher Corp
- 8.4.1 Danaher Corp Company Information
- 8.4.2 Danaher Corp Business Overview
- 8.4.3 Danaher Corp Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Danaher Corp Glycobiology & Glycomics Product Portfolio
- 8.4.5 Danaher Corp Recent Developments
- 8.5 Takara Bio
- 8.5.1 Takara Bio Company Information
- 8.5.2 Takara Bio Business Overview
- 8.5.3 Takara Bio Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Takara Bio Glycobiology & Glycomics Product Portfolio
- 8.5.5 Takara Bio Recent Developments
- 8.6 Sigma-Aldrich Corp
- 8.6.1 Sigma-Aldrich Corp Company Information
- 8.6.2 Sigma-Aldrich Corp Business Overview
- 8.6.3 Sigma-Aldrich Corp Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sigma-Aldrich Corp Glycobiology & Glycomics Product Portfolio
- 8.6.5 Sigma-Aldrich Corp Recent Developments
- 8.7 Prozyme
- 8.7.1 Prozyme Company Information
- 8.7.2 Prozyme Business Overview
- 8.7.3 Prozyme Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Prozyme Glycobiology & Glycomics Product Portfolio
- 8.7.5 Prozyme Recent Developments
- 8.8 New England Biolabs
- 8.8.1 New England Biolabs Company Information
- 8.8.2 New England Biolabs Business Overview
- 8.8.3 New England Biolabs Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 New England Biolabs Glycobiology & Glycomics Product Portfolio
- 8.8.5 New England Biolabs Recent Developments
- 8.9 Bruker Corp
- 8.9.1 Bruker Corp Company Information
- 8.9.2 Bruker Corp Business Overview
- 8.9.3 Bruker Corp Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bruker Corp Glycobiology & Glycomics Product Portfolio
- 8.9.5 Bruker Corp Recent Developments
- 8.10 Agilent Technologies
- 8.10.1 Agilent Technologies Company Information
- 8.10.2 Agilent Technologies Business Overview
- 8.10.3 Agilent Technologies Glycobiology & Glycomics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Agilent Technologies Glycobiology & Glycomics Product Portfolio
- 8.10.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glycobiology & Glycomics Value Chain Analysis
- 9.1.1 Glycobiology & Glycomics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glycobiology & Glycomics Production Mode & Process
- 9.2 Glycobiology & Glycomics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glycobiology & Glycomics Distributors
- 9.2.3 Glycobiology & Glycomics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst